206 related articles for article (PubMed ID: 23140663)
1. Dopamine D2 receptor antagonism suppresses tau aggregation and neurotoxicity.
McCormick AV; Wheeler JM; Guthrie CR; Liachko NF; Kraemer BC
Biol Psychiatry; 2013 Mar; 73(5):464-71. PubMed ID: 23140663
[TBL] [Abstract][Full Text] [Related]
2. Worming our way to Alzheimer's disease drug discovery.
Iyer S; Pierce-Shimomura JT
Biol Psychiatry; 2013 Mar; 73(5):396-8. PubMed ID: 23399470
[No Abstract] [Full Text] [Related]
3. DOPA Decarboxylase Modulates Tau Toxicity.
Kow RL; Sikkema C; Wheeler JM; Wilkinson CW; Kraemer BC
Biol Psychiatry; 2018 Mar; 83(5):438-446. PubMed ID: 28751068
[TBL] [Abstract][Full Text] [Related]
4. Potential neuroprotective strategies against tauopathy.
Wheeler JM; Guthrie CR; Kraemer BC
Biochem Soc Trans; 2012 Aug; 40(4):656-60. PubMed ID: 22817711
[TBL] [Abstract][Full Text] [Related]
5. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy.
Kraemer BC; Zhang B; Leverenz JB; Thomas JH; Trojanowski JQ; Schellenberg GD
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9980-5. PubMed ID: 12872001
[TBL] [Abstract][Full Text] [Related]
6. The role of MSUT-2 in tau neurotoxicity: a target for neuroprotection in tauopathy?
Wheeler JM; Guthrie CR; Kraemer BC
Biochem Soc Trans; 2010 Aug; 38(4):973-6. PubMed ID: 20658987
[TBL] [Abstract][Full Text] [Related]
7. V363I and V363A mutated tau affect aggregation and neuronal dysfunction differently in C. elegans.
Morelli F; Romeo M; Barzago MM; Bolis M; Mattioni D; Rossi G; Tagliavini F; Bastone A; Salmona M; Diomede L
Neurobiol Dis; 2018 Sep; 117():226-234. PubMed ID: 29936232
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity.
Fatouros C; Pir GJ; Biernat J; Koushika SP; Mandelkow E; Mandelkow EM; Schmidt E; Baumeister R
Hum Mol Genet; 2012 Aug; 21(16):3587-603. PubMed ID: 22611162
[TBL] [Abstract][Full Text] [Related]
9. SUT-1 enables tau-induced neurotoxicity in C. elegans.
Kraemer BC; Schellenberg GD
Hum Mol Genet; 2007 Aug; 16(16):1959-71. PubMed ID: 17576746
[TBL] [Abstract][Full Text] [Related]
10. MSUT2 is a determinant of susceptibility to tau neurotoxicity.
Guthrie CR; Greenup L; Leverenz JB; Kraemer BC
Hum Mol Genet; 2011 May; 20(10):1989-99. PubMed ID: 21355046
[TBL] [Abstract][Full Text] [Related]
11. Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.
Hannan SB; Dräger NM; Rasse TM; Voigt A; Jahn TR
J Neurochem; 2016 Apr; 137(1):12-25. PubMed ID: 26756400
[TBL] [Abstract][Full Text] [Related]
12. SPOP loss of function protects against tauopathy.
Eck RJ; Kow RL; Black AH; Liachko NF; Kraemer BC
Proc Natl Acad Sci U S A; 2023 Jan; 120(1):e2207250120. PubMed ID: 36574656
[TBL] [Abstract][Full Text] [Related]
13.
Pir GJ; Choudhary B; Mandelkow E
FASEB J; 2017 Dec; 31(12):5137-5148. PubMed ID: 29191965
[TBL] [Abstract][Full Text] [Related]
14. Glutamatergic nervous system degeneration in a C. elegans Tau
Choudhary B; Mandelkow E; Mandelkow EM; Pir GJ
Neurobiol Dis; 2018 Sep; 117():189-202. PubMed ID: 29894752
[TBL] [Abstract][Full Text] [Related]
15. Curcumin improves tau-induced neuronal dysfunction of nematodes.
Miyasaka T; Xie C; Yoshimura S; Shinzaki Y; Yoshina S; Kage-Nakadai E; Mitani S; Ihara Y
Neurobiol Aging; 2016 Mar; 39():69-81. PubMed ID: 26923403
[TBL] [Abstract][Full Text] [Related]
16. Tau phosphorylation and aggregation as a therapeutic target in tauopathies.
Badiola N; Suárez-Calvet M; Lleó A
CNS Neurol Disord Drug Targets; 2010 Dec; 9(6):727-40. PubMed ID: 20942789
[TBL] [Abstract][Full Text] [Related]
17. Generation of a human induced pluripotent stem cell-based model for tauopathies combining three microtubule-associated protein TAU mutations which displays several phenotypes linked to neurodegeneration.
García-León JA; Cabrera-Socorro A; Eggermont K; Swijsen A; Terryn J; Fazal R; Nami F; Ordovás L; Quiles A; Lluis F; Serneels L; Wierda K; Sierksma A; Kreir M; Pestana F; Van Damme P; De Strooper B; Thorrez L; Ebneth A; Verfaillie CM
Alzheimers Dement; 2018 Oct; 14(10):1261-1280. PubMed ID: 30036493
[TBL] [Abstract][Full Text] [Related]
18. Loss of aly/ALYREF suppresses toxicity in both tau and TDP-43 models of neurodegeneration.
Kow RL; Black AH; Saxton AD; Liachko NF; Kraemer BC
Geroscience; 2022 Apr; 44(2):747-761. PubMed ID: 35122183
[TBL] [Abstract][Full Text] [Related]
19. Progressive neurodegeneration in C. elegans model of tauopathy.
Miyasaka T; Ding Z; Gengyo-Ando K; Oue M; Yamaguchi H; Mitani S; Ihara Y
Neurobiol Dis; 2005 Nov; 20(2):372-83. PubMed ID: 16242642
[TBL] [Abstract][Full Text] [Related]
20. Neuron-selective toxicity of tau peptide in a cell culture model of neurodegenerative tauopathy: essential role for aggregation in neurotoxicity.
Zhao K; Ippolito G; Wang L; Price V; Kim MH; Cornwell G; Fulenchek S; Breen GA; Goux WJ; D'Mello SR
J Neurosci Res; 2010 Nov; 88(15):3399-413. PubMed ID: 20882568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
